GENEQUINE BIOTHERAPEUTICS GMBH

genequine-biotherapeutics-gmbh-logo

GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.

#SimilarOrganizations #People #Financial #Website #More

GENEQUINE BIOTHERAPEUTICS GMBH

Social Links:

Industry:
Biopharma Biotechnology Developer Tools Health Care

Founded:
2011-01-01

Address:
Hamburg, Hamburg, Germany

Country:
Germany

Website Url:
http://www.genequine.com

Total Employee:
1+

Status:
Active

Contact:
49 40 766 29 28 51

Total Funding:
9.89 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apache Mobile Non Scaleable Content Euro Microsoft Exchange Online Cloudflare JS CDN JS JQuery CDN


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

Current Employees Featured

stanislav-plutizki_image

Stanislav Plutizki
Stanislav Plutizki COO @ GeneQuine Biotherapeutics GmbH
COO
2018-01-01

kilian-guse_image

Kilian Guse
Kilian Guse Founder & CEO @ GeneQuine Biotherapeutics GmbH
Founder & CEO

Founder


kilian-guse_image

Kilian Guse

stanislav-plutizki_image

Stanislav Plutizki

Investors List

pacira-pharmaceuticals_image

Pacira Pharmaceuticals

Pacira Pharmaceuticals investment in Series A - GeneQuine Biotherapeutics GmbH

meusinvest_image

Meusinvest (Noshaq)

Meusinvest (Noshaq) investment in Series A - GeneQuine Biotherapeutics GmbH

high-tech-grรผnderfonds_image

High-Tech Grunderfonds

High-Tech Grunderfonds investment in Series A - GeneQuine Biotherapeutics GmbH

pacira-pharmaceuticals_image

Pacira Pharmaceuticals

Pacira Pharmaceuticals investment in Debt Financing - GeneQuine Biotherapeutics GmbH

high-tech-grรผnderfonds_image

High-Tech Grunderfonds

High-Tech Grunderfonds investment in Seed Round - GeneQuine Biotherapeutics GmbH

ifb-innovationsstarter-gmbh_image

IFB Innovationsstarter

IFB Innovationsstarter investment in Seed Round - GeneQuine Biotherapeutics GmbH

Official Site Inspections

http://www.genequine.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.33 K

  • Host name: 217-160-0-180.elastic-ssl.ui-r.com
  • IP address: 217.160.0.180
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Genequine.com lookup results from whois.ionos.com server:
  • Domain created: 29th-Apr-2011
  • Domain updated: 29th-Apr-2024
  • Domain expires: 29th-Apr-2025 0 Years, 64 Days left
  • Website age: 13 Years, 301 Days
  • Registrar Domain ID: 1653441443_DOMAIN_COM-VRSN
  • Registrar Url: http://www.ionos.com
  • Registrar WHOIS Server: whois.ionos.com
  • Registrar Abuse Contact Email: abuse@ionos.com
  • Registrar Abuse Contact Phone: +1.6105601459
  • Name server:
    • NS1029.UI-DNS.BIZ
    • NS1029.UI-DNS.COM
    • NS1029.UI-DNS.DE
    • NS1029.UI-DNS.ORG

More informations about "GeneQuine Biotherapeutics GmbH" on Search Engine